Celsion (NASDAQ: CLSN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-19 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.990 | -1.820 | -0.8300 | ||||
REV | 100.000K | 125.000K | 25.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Celsion (NASDAQ: CLSN) through any online brokerage.
Other companies in Celsion’s space includes: Allena Pharma (NASDAQ:ALNA), Biocept (NASDAQ:BIOC), T2 Biosystems (NASDAQ:TTOO), Calithera Biosciences (NASDAQ:CALA) and ABVC BioPharma (NASDAQ:ABVC).
The latest price target for Celsion (NASDAQ: CLSN) was reported by HC Wainwright & Co. on Wednesday, April 13, 2022. The analyst firm set a price target for 16.00 expecting CLSN to rise to within 12 months (a possible 529.92% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Celsion (NASDAQ: CLSN) is $2.54 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Celsion.
Celsion’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for Celsion.
Celsion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.